Anda belum login :: 23 Nov 2024 10:04 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Concomitant Augmentation of Type 1 CD4+ and CD8+ T-Cell Responses During Successful Interferon-(alpha) and Ribavirin Treatment for Chronic Hepatitis C Virus Infection (from Human Immunology 2003, Vol. 64, 497-504)
Bibliografi
Author:
Sreenarasimhaiah, Jayaprakash
;
Jaramillo, Andres
;
Crippin, Jeffrey
;
Lisker-Melman, Mauricio
;
Chapman, William C.
;
Mohanakumar, T.
Topik:
CD4(alpha) T cells
;
CD8(alpha) T cells
;
hepatitis C virus
;
IFN-(alpha)/ribavirin therapy
;
Validation ref - 2
;
20
Bahasa:
(EN )
Penerbit:
Elsevier
Tahun Terbit:
2003
Jenis:
Article - diterbitkan di jurnal ilmiah internasional
Fulltext:
sreenarasimhaiah2003.pdf
(176.99KB;
0 download
)
Abstract
The combined interferon-(alpha_ (IFN-alpha)) and ribavirin (IFN-(alpha)/ribavirin) therapy for chronic hepatitis C virus (HCV) infection results in sustained viral eradication in 31%–64% of the patients. Previous studies have strongly suggested that HCV-specific T-cell responses maybe modulated during this therapy. The objective of this study was to further define the effect of IFN-(alpha)/ ribavirin therapy on type 1 and type 2 HCV-specific CD4(alpha) and CD8(alpha) T-cell responses during IFN-(alpha)/ribavirin therapy. Toward this, serial CD8(alpha) T-cell responses to HCV-derived epitopes and CD4(alpha) T-cell responses to the HCV core antigen were analyzed in four patients before(baseline), during (at 24 weeks), and at the end (at 48 weeks) of IFN-(alpha)/ribavirin therapy. Therapy-induced viral clearance in three patients was associated with a significant augmentation of HCV-specific type 1 CD4(alpha) and CD8(alpha) T-cell responses. In contrast, in a patient who did not respond to therapy, a significant HCV-specific CD4(alpha) Th2 cell reactivity was observed accompanied by a lack of augmentation of the HCV-specific CD8(alpha) T-cell reactivity. These results indicate that enhancement of HCVspecific CD4(alpha) and CD8(alpha) T-cell responses is an important factor in determining the response to the IFN-(alpha)/ribavirin therapy and the outcome of the HCV infection.
[validation ref - 2, 20]
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Lihat Sejarah Pengadaan
Konversi Metadata
Kembali
Process time: 0.171875 second(s)